pemetrexed baxter
baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - Æxlishemjandi lyf - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.
hjartamagnýl magasýruþolin tafla 75 mg
teva b.v.* - acidum acetylsalicylicum - magasýruþolin tafla - 75 mg
parkódín filmuhúðuð tafla 500 mg/10 mg
teva b.v.* - paracetamolum inn; codeini phosphas hemihydricus - filmuhúðuð tafla - 500 mg/10 mg
parkódín forte filmuhúðuð tafla 500 mg/30 mg
teva b.v.* - paracetamolum inn; codeini phosphas hemihydricus - filmuhúðuð tafla - 500 mg/30 mg
pemetrexed w&h stofn fyrir innrennslisþykkni, lausn 500 mg
williams & halls ehf. - pemetrexedum dínatríum - stofn fyrir innrennslisþykkni, lausn - 500 mg
pemetrexed wh (pemetrexed synthon) innrennslisþykkni, lausn 25 mg/ml
williams & halls ehf. - pemetrexedum inn - innrennslisþykkni, lausn - 25 mg/ml
prograf hart hylki 0,5 mg
astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 0,5 mg
prograf hart hylki 1 mg
astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 1 mg
prograf hart hylki 5 mg
astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 5 mg
tegretol mixtúra, dreifa 20 mg/ml
novartis healthcare a/s - carbamazepinum inn - mixtúra, dreifa - 20 mg/ml